Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc for a generic combination product containing four amphetamine salts (dextroamphetami…
-
FDA approval · 2023-10-13FDA Approved: DYANAVEL XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for DYANAVEL XR (amphetamine) filed by NextWave Pharmaceuticals, Inc.
-
FDA approval · 2023-10-13FDA Approved: QUILLICHEW ER — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for Quillichew ER (methylphenidate hydrochloride) from NextWave Pharmaceuticals. The action upda…
-
FDA approval · 2023-10-13FDA Approved: AMPHETAMINE EXTENDED-RELEASE — Supplemental Application (Neos Therapeutics, LP)
The FDA approved a supplemental application for an extended-release formulation of amphetamine from Neos Therapeutics, LP.
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved a supplemental application for a generic dextr oamphetamine sulfate product from Lupin Pharmaceuticals, authorizing its continu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-10-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride from Rising Pharma Holdings, Inc., authorizing its continued marke…
-
FDA approval · 2023-10-13FDA Approved: COTEMPLA XR-ODT — Supplemental Application (Neos Therapeutics Brands, LLC)
The FDA approved a supplemental application for Cotempla XR-ODT (methylphenidate) from Neos Therapeutics Brands, LLC.
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (SUNRISE PHARMACEUTICAL, INC.)
The FDA approved a supplemental application for dextroamphetamine sulfate submitted by Sunrise Pharmaceutical, Inc.
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (SUNRISE PHARMACEUTICAL, INC.)
The FDA approved Sunrise Pharmaceutical's supplemental application for a four-salt amphetamine product (dextroamphetamine saccharate, amphet…
-
FDA approval · 2023-10-13FDA Approved: AZSTARYS — Supplemental Application (Corium, LLC.)
The FDA approved a supplemental application for AZSTARYS (serdexmethylphenidate and dexmethylphenidate) from Corium, LLC.
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental application for a generic combination product containing four amphetamine salts: dextroamp…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for a combination amphetamine/dextroamphetamine product from Granules Pharmaceuticals Inc. containin…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Supplemental Application (Neolpharma, Inc.)
FDA approved a supplemental application for a generic combination of dextroamphetamine and amphetamine salts manufactured by Neolpharma, Inc…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
The FDA approved a supplemental application for dextroamphetamine sulfate (generic) from Cranbury Pharmaceuticals, enabling the marketing of…
-
FDA approval · 2023-10-13FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental NDA for the methylphenidate transdermal system, sponsored by PADAGIS US LLC.
-
FDA approval · 2023-10-13FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) from Janssen Pharmaceuticals, Inc. The approval upd…
-
FDA approval · 2023-10-13FDA Approved: EVEKEO — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EVEKEO (amphetamine sulfate) submitted by Azurity Pharmaceuticals, Inc.
-
FDA approval · 2023-10-13FDA Approved: QUILLIVANT XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
The FDA approved a supplemental application for QUILLIVANT XR (methylphenidate hydrochloride) from NextWave Pharmaceuticals, Inc. The docume…
-
FDA approval · 2023-10-13FDA Approved: MYDAYIS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for MYDAYIS (mixed amphetamine salts) from Takeda, updating the drug’s labeling per the supplemental…
-
FDA label_change · 2023-10-13FDA Approved: JORNAY PM EXTENDED-RELEASE — Supplemental Application (Ironshore Pharmaceuticals Inc.)
FDA approved a supplemental application for Jornay PM Extended-Release (methylphenidate hydrochloride) from Ironshore Pharmaceuticals Inc., …
-
FDA approval · 2023-10-13FDA Approved: DYANAVEL XR — Supplemental Application (NextWave Pharmaceuticals, Inc)
FDA approved a supplemental NDA for DYANAVEL XR (amphetamine) submitted by NextWave Pharmaceuticals, Inc.
-
FDA approval · 2023-10-13FDA Approved: XELSTRYM — Supplemental Application (Noven Therapeutics, LLC)
FDA approved a supplemental application for XELSTRYM (dextroamphetamine) from Noven Therapeutics, LLC. The snippet does not specify the exac…
-
FDA approval · 2023-10-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Trigen Laboratories, LLC)
FDA approved a supplemental application for methylphenidate hydrochloride from Trigen Laboratories, LLC.
-
FDA label_change · 2023-10-13FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) submitted by Amneal Pharmaceuticals LLC. This…
-
FDA approval · 2023-10-13FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application from Sun Pharmaceutical Industries for a generic product comprising four amphetamine salt compon…